WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Hits New 12-Month High – Should You Buy?

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWYGet Free Report) shares hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $11.55 and last traded at $11.50, with a volume of 20618 shares changing hands. The stock had previously closed at $10.16.

WuXi Biologics (Cayman) Stock Up 9.1%

The firm has a fifty day moving average of $8.98 and a 200-day moving average of $9.10.

WuXi Biologics (Cayman) Company Profile

(Get Free Report)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.

Recommended Stories

Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.